Katherine High
Scientific Advisory Group Member at Pathway to Cures
About
Visiting professor at Rockefeller University and board member of Incyte, CRISPR Therapeutics, and Virion Therapeutics. Co-founder of Spark Therapeutics with pioneering research in AAV-mediated gene therapy for hemophilia and membership in the National Academy of Medicine and Sciences.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Haiyan Jiang
Scientific Advisory Group Member at Pathway to Cures
Leonard Valentino
P2C Entrepreneur in Residence and CEO at Pathway to Cures
Michael Recht
Chair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
Peter Harvey
P2C Chief Financial Officer and NBDF Chief Business Officer at Pathway to Cures